US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

18.36

+0.07930.43%

Post-market: 18.30-0.0588-0.32%19:30 EDT

Volume:30.01K

Turnover:549.75K

Market Cap:108.32M

PE:- -

High:18.43

Open:18.31

Low:18.20

Close:18.28

52wk High:21.50

52wk Low:14.38

Shares:5.90M

Float Shares:5.90M

Volume Ratio:1.09

T/O Rate:0.51%

Dividend:0.71

Dividend Rate:3.89%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Uni-Bio Science H1 Revenue Falls 12% on Pricing Changes

CSPC Pharma's SYS6090 (JMT108) Receives FDA Fast Track Designation for MSS/pMMR Metastatic Colorectal Cancer Treatment

BEONE MEDICINES Reports Strong First-Half Profit Surge of 385.8%

Southbound Capital Insights: Net Buying Hits HK$453 Million, Innovent Bio Faces Heavy Selling After Earnings Surge

CSPC Pharma Says FDA Grants Fast Track Status to Sys6090 for MSS/pMMR Metastatic Colorectal Cancer

CSPC Pharma's SYS6010 Achieves Primary Endpoint in Phase III Trial for EGFR-Mutant NSCLC Patients

CSPC Pharmaceutical - Sys6090 (Jmt108) Granted Fast Track Designation by U.S. FDA for Mss/Pmmr Mcrc

THOMSON REUTERS

CSPC Pharmaceutical - Sys6010 Meets Primary Endpoint of Progression-Free Survival in Phase Iii Synstar-01 Study

THOMSON REUTERS

CSPC Pharmaceutical Group Stock Rallies 1.2% in Hong Kong, Underperforms Competitors

CICC Maintains Outperform Rating on Innovent Biologics with Target Price Set at HK$118.30

-BUZZ-China's Innovent Biologics Hits All-Time High on H1 Growth

Hong Kong Biotech Sector Surges Again as Innovative Drug Stocks Lead Gains, INNOVENT BIO Hits Record High

China, HK Stocks Track Global Tech Rebound; Gold Miners Rally

Hong Kong's SSY Group H1 Profit Rises on Infusion Solutions Growth

Sihuan Pharmaceutical H1 Profit Jumps on Medical Aesthetics Unit Strength

Morning Market Wrap: Hong Kong Shares Rise 0.68% as Copper Stocks Take the Lead

Mainland Benchmarks Edge Higher in Morning Trade; Nonferrous Metals and Brokerages Lead While Optical Modules Retreat; Hang Seng and Tech Index Climb Over 1% on Biotech Surge

China's Akeso Jumps on Progress of Immunotherapy Drug for Cancer Treatment

AKESO Surges Over 9% in Session as Evonex Achieves Positive Phase III Results in Biliary Tract Cancer

Akeso's Ivonescimab Meets Primary Endpoint in Phase 3 Biliary Tract Cancer Trial

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/KURE/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":18.3593,"timestamp":1789761600000,"preClose":18.28,"halted":0,"volume":30007,"hourTrading":{"tag":"盘后","latestPrice":18.3005,"preClose":18.3593,"latestTime":"19:30 EDT","volume":9,"amount":164.8058,"timestamp":1789774205135,"change":-0.0588,"changeRate":-0.003203,"amplitude":0},"delay":0,"changeRate":0.004338074398249449,"floatShares":5900168,"shares":5900168,"eps":0,"marketStatus":"Market Closed","change":0.0793,"latestTime":"09-18 16:00:00 EDT","open":18.31,"high":18.4299,"low":18.2,"amount":549746.6642979999,"amplitude":0.012577,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":18.28,"sharesOutstanding":4750002,"nav":18.2,"aum":106490719.49,"dividendRate":0.038934,"bidAskSpread":0.011872,"postHourTrading":{"tag":"盘后","latestPrice":18.3005,"preClose":18.3593,"latestTime":"19:30 EDT","volume":9,"amount":164.8058,"timestamp":1789774205135,"change":-0.0588,"changeRate":-0.003203,"amplitude":0},"volumeRatio":1.0912112465055275,"impliedVol":0.1722,"impliedVolPercentile":0.3665},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5900168,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0912112465055275,"shares":5900168,"dividePrice":0.7148,"high":18.4299,"amplitude":0.012577,"preClose":18.28,"low":18.2,"week52Low":14.3797,"pbRate":"--","week52High":21.5,"institutionHeld":0,"latestPrice":18.3593,"eps":0,"divideRate":0.038934,"volume":30007,"delay":0,"ttmEps":0,"open":18.31,"prevYearClose":17.04,"prevWeekClose":17.74,"prevMonthClose":18.54,"prevQuarterClose":15.747,"fiveDayClose":17.74,"twentyDayClose":19.34,"sixtyDayClose":15.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662797145","title":"Uni-Bio Science H1 Revenue Falls 12% on Pricing Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2662797145","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662797145?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:18","pubTimestamp":1787739506,"startTime":"0","endTime":"0","summary":"Uni-Bio Science H1 revenue falls 12% on pricing changesOverviewHong Kong-listed biopharma firm's H1 2026 revenue fell 12% yr/yr amid pricing adjustmentsNet profit dropped 59% as R+D and commercializat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N0D4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494708.USD","LU2347655073.USD","MEDX","IE000BZT7R73.USD","IE000MB6IJN5.SGD","LU2129689605.HKD","IE0009355771.USD","LU0820561909.HKD","RXL","LU0057025933.USD","IE0002270589.USD","BK1583","00690","JDOC","BK1191","IE00BLSP4452.SGD","XLV","IE000WAW04H5.SGD","LU0203347892.USD","IXJ","LU1989772840.SGD","LU1934455277.USD","LU0122379950.USD","BK4533","PJP","LU2133065610.SGD","LU0211328371.USD","PPH","LU0211327993.USD","SG9999015986.USD","VHT","03692","IE00B19Z3581.USD","LU0985320562.USD","BK4581","FHLC","KURE","GLAM","01801","IYH","ABBV","TRUH","LU0234572021.USD","BK4588","LU0203345920.USD","688331","IE00B2B36J28.USD","AGNG","FTXH","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119638338","title":"CSPC Pharma's SYS6090 (JMT108) Receives FDA Fast Track Designation for MSS/pMMR Metastatic Colorectal Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1119638338","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119638338?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:18","pubTimestamp":1787739482,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) has announced that its first-in-class PD-1/IL-15 bispecific fusion protein, SYS6090 (JMT108), has been granted Fast Track designation by the U.S. Food and Drug Administration...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4113","LU1807302812.USD","IE00BZ08YS42.EUR","MSS","LU1226287875.USD","LU1328277881.USD","BK1191","LU1813983027.USD","LU1960683339.HKD","BK4588","BK4585","IE00B5MMRT66.SGD","LU0140636845.USD","LU1152091754.HKD","LU0072913022.USD","LU1152091168.USD","LU0067412154.USD","IE00B031HY20.USD","HK0000165453.HKD","LU2039709279.SGD","BK1521","LU1008478684.HKD","SG9999004220.SGD","IE00BZ08YR35.GBP","LU0315179316.USD","IE0008369823.USD","LU1951186391.HKD","LABU","LU1993786604.SGD","KURE","LU0326950275.SGD","01093","IE0008368742.USD","LU0314109678.HKD","LU1226287529.USD","BK1515","LU1226288253.USD","IE00BZ08YT58.USD","LU1226287792.SGD","LU0501845795.SGD","LU1226288170.HKD","IE00B543WZ88.USD","LU0880133367.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107537379","title":"BEONE MEDICINES Reports Strong First-Half Profit Surge of 385.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107537379","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107537379?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:16","pubTimestamp":1787739404,"startTime":"0","endTime":"0","summary":"BEONE MEDICINES (06160) has unveiled its interim results for the six months ended June 30, 2026, posting a net profit of $464 million, a substantial year-on-year increase of 385.8%.The company's...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","688235","LU1770034418.SGD","LU0588546209.SGD","LU0228659784.USD","BK1500","KURE","LU0828237510.HKD","BK1161","LU1303224171.USD","BK4588","LU1719994722.HKD","BK1588","LU2328871848.SGD","06160","BK4585","LU1251922891.USD","ONC","BK4526","LU1969619763.USD","BK1583","LU0307460666.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124902197","title":"Southbound Capital Insights: Net Buying Hits HK$453 Million, Innovent Bio Faces Heavy Selling After Earnings Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1124902197","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124902197?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:11","pubTimestamp":1787739111,"startTime":"0","endTime":"0","summary":"On August 26th in the Hong Kong stock market, southbound capital recorded a net buy of HK$453 million. Specifically, the Shanghai-Hong Kong Stock Connect saw a net sell of HK$1.125 billion, while the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","LU0455707207.USD","LU1969619763.USD","LU2097828557.USD","BK1583","LU2328871848.SGD","LU1188198961.HKD","LU2242644610.SGD","HK0000165453.HKD","LU0244354667.USD","LU0502904849.HKD","KURE","01801","BK1161","LU2097828474.EUR","LU2097828714.EUR","LU2097828631.EUR","LU2097828805.USD","LU0326950275.SGD","LU2488822045.USD","LU0463099449.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662679768","title":"CSPC Pharma Says FDA Grants Fast Track Status to Sys6090 for MSS/pMMR Metastatic Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662679768","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662679768?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:11","pubTimestamp":1787739093,"startTime":"0","endTime":"0","summary":"CSPC Pharma says FDA grants Fast Track status to SYS6090 for MSS/pMMR metastatic colorectal cancerCSPC Pharmaceutical’s SYS6090 (JMT108) won US FDA Fast Track designation for MSS/pMMR metastatic color","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL2W16sV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1951186391.HKD","IE00BZ08YS42.EUR","LU1226288170.HKD","LU0501845795.SGD","LU1152091168.USD","KURE","LU1152091754.HKD","LU0315179316.USD","LU1226288253.USD","IE0008368742.USD","BK1515","LU0314109678.HKD","LU1008478684.HKD","BK1191","LU0067412154.USD","IE00B031HY20.USD","01093","SG9999004220.SGD","IE00BZ08YT58.USD","LU0880133367.SGD","LU0140636845.USD","BK1521","LU1226287875.USD","IE00B543WZ88.USD","IE00BZ08YR35.GBP","LU1813983027.USD","IE00B5MMRT66.SGD","LU0326950275.SGD","LU1807302812.USD","IE0008369823.USD","LU1993786604.SGD","LU1328277881.USD","LU1960683339.HKD","HK0000165453.HKD","LU1226287529.USD","LU1226287792.SGD","LU0072913022.USD","LU2039709279.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115485763","title":"CSPC Pharma's SYS6010 Achieves Primary Endpoint in Phase III Trial for EGFR-Mutant NSCLC Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=1115485763","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115485763?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:10","pubTimestamp":1787739028,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that its investigational drug SYS6010 successfully met the predefined primary endpoint of progression-free survival (PFS) in the Phase III clinical study SYNSTAR-01....","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328277881.USD","01093","LU0072913022.USD","IE00BZ08YR35.GBP","IE0008369823.USD","SG9999004220.SGD","LU1807302812.USD","LU0314109678.HKD","BK1521","IE00B031HY20.USD","BK1515","LU1226288170.HKD","KURE","III","LU1226287529.USD","LU1226288253.USD","LU1008478684.HKD","LU0880133367.SGD","LU2039709279.SGD","IE00BZ08YT58.USD","LU1152091168.USD","LU1813983027.USD","LU1960683339.HKD","LU1152091754.HKD","LU0140636845.USD","LU1993786604.SGD","IE00B5MMRT66.SGD","HK0000165453.HKD","LU1951186391.HKD","LU1226287875.USD","BK1191","IE00B543WZ88.USD","IE0008368742.USD","LU1226287792.SGD","LU0315179316.USD","IE00BZ08YS42.EUR","LU0501845795.SGD","BK4134","LU0067412154.USD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662797532","title":"CSPC Pharmaceutical - Sys6090 (Jmt108) Granted Fast Track Designation by U.S. FDA for Mss/Pmmr Mcrc","url":"https://stock-news.laohu8.com/highlight/detail?id=2662797532","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662797532?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:10","pubTimestamp":1787739002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0I5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0880133367.SGD","LU0501845795.SGD","LU1226287792.SGD","LU0326950275.SGD","BK1191","LU0315179316.USD","BK1521","HK0000165453.HKD","LU1226287875.USD","LU1226288253.USD","IE00BZ08YT58.USD","LU1152091168.USD","IE0008368742.USD","LU1328277881.USD","LU1993786604.SGD","LU1960683339.HKD","IE00BZ08YR35.GBP","LU1008478684.HKD","LU1152091754.HKD","LU0314109678.HKD","BK1515","IE00BZ08YS42.EUR","LU1813983027.USD","LU1807302812.USD","LU0140636845.USD","IE00B5MMRT66.SGD","KURE","IE00B031HY20.USD","LU1951186391.HKD","LU0067412154.USD","LU1226287529.USD","LU2039709279.SGD","LU0072913022.USD","IE0008369823.USD","IE00B543WZ88.USD","01093","SG9999004220.SGD","LU1226288170.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662792719","title":"CSPC Pharmaceutical - Sys6010 Meets Primary Endpoint of Progression-Free Survival in Phase Iii Synstar-01 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2662792719","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662792719?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:01","pubTimestamp":1787738500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0KM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0315179316.USD","LU0880133367.SGD","LU1226287875.USD","LU0326950275.SGD","LU2039709279.SGD","LU1226287792.SGD","IE00BZ08YS42.EUR","KURE","LU0501845795.SGD","LU1226288253.USD","LU0072913022.USD","IE00BZ08YR35.GBP","BK1191","LU0067412154.USD","BK1515","LU1226287529.USD","IE00B031HY20.USD","IE0008368742.USD","LU0140636845.USD","IE00B5MMRT66.SGD","01093","LU0314109678.HKD","LU1807302812.USD","LU1813983027.USD","IE00BZ08YT58.USD","SG9999004220.SGD","LU1951186391.HKD","BK1521","LU1960683339.HKD","IE00B543WZ88.USD","LU1152091754.HKD","LU1328277881.USD","LU1993786604.SGD","LU1152091168.USD","IE0008369823.USD","LU1226288170.HKD","HK0000165453.HKD","LU1008478684.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662796413","title":"CSPC Pharmaceutical Group Stock Rallies 1.2% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662796413","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662796413?lang=en_us&edition=fundamental","pubTime":"2026-08-26 16:33","pubTimestamp":1787733180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. advanced 1.2% to 9.53 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.6% to 25652.97.This was the stock's third consecutive day of gains.CSPC Pharmaceutical Group Ltd. closed 18% short of its 52-week high of HK$11.63, which the company achieved Sept. 9.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. rose 2.1%, SSY Group Ltd. rose 5.2%, and United Laboratories International Holdings Ltd. fell 0.8%.Trading volume totaled 190.3 million shares, compared to the 50-day average of 100.7 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0315179316.USD","LU0140636845.USD","LU1807302812.USD","LU0880133367.SGD","LU0067412154.USD","IE00B031HY20.USD","LU1993786604.SGD","01093","LU1328277881.USD","IE0008368742.USD","LU1951186391.HKD","IE00BZ08YT58.USD","LU0326950275.SGD","IE00B5MMRT66.SGD","BK1521","BK1191","LU0314109678.HKD","SG9999004220.SGD","IE0008369823.USD","LU1226287875.USD","IE00B543WZ88.USD","HK0000165453.HKD","LU1226288253.USD","BK1515","LU2039709279.SGD","IE00BZ08YR35.GBP","LU1226287529.USD","LU0072913022.USD","LU1960683339.HKD","LU1008478684.HKD","LU1152091168.USD","LU0501845795.SGD","LU1152091754.HKD","IE00BZ08YS42.EUR","KURE","LU1226288170.HKD","LU1813983027.USD","LU1226287792.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139243882","title":"CICC Maintains Outperform Rating on Innovent Biologics with Target Price Set at HK$118.30","url":"https://stock-news.laohu8.com/highlight/detail?id=1139243882","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139243882?lang=en_us&edition=fundamental","pubTime":"2026-08-26 14:11","pubTimestamp":1787724693,"startTime":"0","endTime":"0","summary":"CICC has released a research report stating that it maintains an outperform rating on INNOVENT BIO (01801), keeping its 2026 net profit attributable to shareholders forecast at RMB 2.43 billion....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","LU2097828714.EUR","LU2097828805.USD","EWH","BK1589","01801","LU0326950275.SGD","KURE","LU0455707207.USD","BK1583","LU0244354667.USD","LU1188198961.HKD","LU2488822045.USD","LU2242644610.SGD","BK1161","LU2097828557.USD","LU2097828474.EUR","LU0502904849.HKD","LU2328871848.SGD","LU0463099449.HKD","LU2097828631.EUR","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662540760","title":"-BUZZ-China's Innovent Biologics Hits All-Time High on H1 Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2662540760","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662540760?lang=en_us&edition=fundamental","pubTime":"2026-08-26 14:09","pubTimestamp":1787724588,"startTime":"0","endTime":"0","summary":"-BUZZ-China's Innovent Biologics hits all-time high on H1 growthAdds top pct gainer in key index in third bullet, earnings details in fourth bullet** Shares of China's Innovent Biologics1801.HKjump 12","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N03U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURE","BK1161","BK1583","LU2097828714.EUR","01801","LU0502904849.HKD","LU2097828805.USD","LU1188198961.HKD","BK1589","LU2488822045.USD","LU0326950275.SGD","LU2097828631.EUR","LU2242644610.SGD","LU2097828557.USD","LU0455707207.USD","HK0000165453.HKD","LU2328871848.SGD","LU0463099449.HKD","LU2097828474.EUR","LU1969619763.USD","LU0244354667.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149059268","title":"Hong Kong Biotech Sector Surges Again as Innovative Drug Stocks Lead Gains, INNOVENT BIO Hits Record High","url":"https://stock-news.laohu8.com/highlight/detail?id=1149059268","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149059268?lang=en_us&edition=fundamental","pubTime":"2026-08-26 14:02","pubTimestamp":1787724134,"startTime":"0","endTime":"0","summary":"Hong Kong healthcare stocks continued their upward momentum on August 26, with innovative drug developers taking over the leadership baton from the CXO sector. Cansino Biologics Inc. soared more than...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","LU0455707207.USD","MEDX","159992","LU1969619763.USD","BK0239","LU2097828557.USD","BK1583","LU2328871848.SGD","IBBQ","LU1188198961.HKD","06978","LU2242644610.SGD","688185","HK0000165453.HKD","LU0244354667.USD","LU0502904849.HKD","FLHK","KURE","01801","BK1161","BK1574","LU2097828474.EUR","LU2097828714.EUR","LU2097828631.EUR","LNGR","LU2097828805.USD","LU0326950275.SGD","159646","LU2488822045.USD","LU0463099449.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662640467","title":"China, HK Stocks Track Global Tech Rebound; Gold Miners Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2662640467","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662640467?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:27","pubTimestamp":1787718464,"startTime":"0","endTime":"0","summary":"China, HK stocks track global tech rebound; gold miners rallySHANGHAI, August 26 (Reuters)-China and Hong Kong stocks advanced on Wednesday, tracking a broader rebound in global markets as sentiment i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N034:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09988","LU0651947912.USD","LU0611395673.USD","IE00BFSS8Q28.SGD","IE000YTNTUN2.SGD","LU0051755006.USD","SG9999004220.SGD","LU1981816686.USD","LU0791591158.USD","LU0259732245.USD","LU0149534421.HKD","LU2125910500.SGD","IE00BKVL7J92.USD","LAZR","LDEM","LU0198837287.USD","SG9999015358.SGD","LU1861215975.USD","SG9999002562.SGD","LU0187121727.USD","LU0823039010.USD","JGRO","LU0175139822.USD","XLK","AIPI","LU0235996351.USD","LITU","SOXX","IE00BZ08YT58.USD","CHPX","LU2381873111.SGD","LU0012050646.USD","03037","LU1328615791.USD","LU1267930730.SGD","LU0096362180.USD","LU0138981039.USD","LU2023251221.USD","LU0254981946.USD","LU0689472784.USD","LU1803068979.SGD","SGXZ81514606.USD","HK0000286598.CNH","IE00BZ1G4Q59.USD","LU0964807845.USD","LU2552382058.USD","LU0011850046.USD","LU0823434740.USD","VGT","LU1084165304.USD","LU0589944569.HKD","LU0861579265.USD","LU2347655156.SGD","IE0003895053.USD","LU2100268510.USD","LU2487616109.SGD","LU0348783233.USD","LU0315179316.USD","AIFD","LU0173614495.USD","LU0577902538.SGD","LU0865486749.SGD","LU1435385759.SGD","LU2152927971.USD","LU0326950275.SGD","LU1791710582.SGD","BK1575","LU0354030511.USD","LU2394011477.USD","IE00B4YYXB79.USD","LU0106959298.USD","LU2592432038.USD","LU0163747925.USD","LU0196878994.USD","LU0197773673.USD","LU0164880469.USD","LU2125909593.SGD","LU0267386448.USD","GAMR","HK0000107257.USD","LU0211328371.USD","LU1119994496.HKD","LU1674673428.USD","NVDO","SG9999014880.SGD","LU1323998911.USD","LU2065171311.SGD","SG9999001051.SGD","LU1719994722.HKD","LU0106261612.USD","BK4554","LU0823414478.USD","BK1249","LU0070217475.USD","LU2637965513.SGD","LU2286300806.USD","BK4592","SG9999006514.SGD","LU1645745479.HKD","IETC","BK1610","LU1515016050.SGD","LU0738911758.USD","LU1935042215.USD","LU0605514214.HKD","CNEQ","LU0329678337.USD","LU0868494708.USD","LU0630378692.HKD","LU2322448957.HKD","LU0516422366.SGD","LU2491050154.USD","LU1720050803.USD","IE0034235303.USD","NVDU","LU0476273544.USD","LU2430703095.HKD","LU0689626769.HKD","LU0039217434.USD","LU0320764599.SGD","SG9999001093.SGD","LU2476274308.USD","LU1992135472.HKD","HK0000819398.USD","LU0069063385.USD","LU0169518387.USD","LU2290526834.HKD","BK1584","BKF","IE0008368304.USD","IE00BJTD4V19.USD","LU1691799644.USD","SG9999018865.SGD","LU1815333072.USD","LU1066051498.USD","SG9999002224.SGD","LU0210526637.USD","LU1732799900.SGD","LU1831875114.USD","LU1282649067.USD","IE0034224299.USD","LU0823397285.USD","BK1588","LU0819121731.USD","LU0348735423.USD","LU1629891620.HKD","BK4585","IE000ITXATA3.USD","LU0708994859.HKD","SGXZ51526630.SGD","FAI","BK1142","LU1496350502.SGD","HHImain","LU1868837565.USD","NVDG","LU1037948897.HKD","SMH","ALBmain","LU2360107168.USD","ROM","LU2999663052.SGD","LU2097828557.USD","LU0726765562.USD","LU0127658192.USD","LU1051769294.HKD","NVDD","USXF","IE00BN29S564.USD","LU0345770993.USD","LU1961090484.USD","TTXU","LU1504937902.USD","HK0000306685.HKD","LU0315178854.USD","LU0225283273.USD","LU1037948541.HKD","IE0004445015.USD","IE00B5TLWC47.USD","LU2237443382.USD","LU0345775950.USD","LU0109391861.USD","LU1770034418.SGD","LU1794554557.SGD","LU0466842654.USD","LU0056508442.USD","LU1244550221.USD","IE00B7KXQ091.USD","LU0329678170.USD","LU0345768740.USD","LU0499858602.USD","LU0823421416.USD","LU2552382215.SGD","LU2896262040.SGD","NVDL","LU2237957811.SGD","LU2347655073.USD","LU2028103732.USD","LU2242650005.HKD","LU2430703251.USD","LU0347712357.USD","SG9999015978.USD","LU0054450605.USD","NVDS.UK","IE00B775H168.HKD","LU0384037296.USD","BK4612","LU1868837136.USD","SOXY","BK4598","LU0608807433.USD","SGXZ90724238.SGD","BK4157","LU0215105999.USD","LU1712237335.SGD","LU0345770308.USD","LU0029875118.USD","LU0203201768.USD","2NVD.UK","IE00B1BXHZ80.USD","GB00BDT5M118.USD","LU0081259029.USD","LU1244550494.USD","FDNI","LU0650527681.SGD","LU2602419157.SGD","LU0949170772.SGD","LU2750360641.GBP","LU0228367735.SGD","LITZ","ESLG","LU2148611432.USD","NVDW","LU0211327993.USD","TTEQ","LU0417517546.SGD","89988","LU2092937148.SGD","LU0276348264.USD","IE00BHPRN162.USD","LU0819123356.HKD","HK0000304805.HKD","LU0214875030.USD","LU0310800379.SGD","03419","LU1720051108.HKD","LU0143551892.USD","LU1224709979.USD","LU2746668974.SGD","HSI","LU1917777945.USD","SNVD.UK","IE00B0169N27.USD","LU2097344431.USD","COHQ","LU2433249047.HKD","LU2242649171.HKD","BK1583","LU0449515922.USD","LITX","LU1935043536.SGD","LU0293314216.USD","LU0348805143.USD","LU1655091459.SGD","LU0124676726.USD","LU0117844026.USD","LU1064131342.USD","BK4551","SG9999000327.SGD","LU0444973449.USD","LU0675040207.SGD","LU2249611893.SGD","LU0006306889.USD","LU0572944931.SGD","LU3102509885.SGD","LU1983260115.SGD","BK1586","LU1808992512.USD","BK1589","LU0228659784.USD","LU0488056044.USD","LU1429558221.USD","BK4148","SHOC","LU0094547139.USD","EFIV","NVDB","HK0000532082.HKD","LU0320764755.SGD","LU0256863811.USD","LU1699723380.USD","COHH","LU0531970944.HKD","CLSE","LU1282651121.HKD","LU2322448791.USD","LU0011963245.USD","LU1989772840.SGD","LU1116320901.HKD","LU2125910849.SGD","IE00BKDWB100.SGD","LU0417516571.SGD","NVD3.UK","SG9999002232.USD","IE00BMPRXQ63.HKD","LU1807302812.USD","LU0211977185.USD","LU2226246903.HKD","LU2125909759.SGD","LU2168564149.EUR","LU2462591277.SGD","LU2491049909.HKD","LU1568876335.HKD","LU2778985437.USD","SG9999002463.SGD","LU2473716301.USD","EGGY","LU0310799852.SGD","LU0868486357.SGD","KURE","LU1969619763.USD","IE00B3M56506.USD","NVC","SG9999002828.SGD","07500","LU0672654240.SGD","LU0080751232.USD","LU0072462343.USD","LU0634319403.HKD","LU0061474960.USD","LU1623119135.USD","BK4549","USD","LU0251144936.SGD","LU0572939691.SGD","LU2543165471.USD","BK1502","LU0106259558.USD","IE00BQXX3F31.USD","LU1232071149.USD","LU2272731782.SGD","NVDY","LU0683600562.USD","LU2293587155.HKD","LU0345769631.USD","LU2092627202.USD","IE00B5MMRT66.SGD","LU0323591593.USD","LU0143863198.USD","LU0737861772.HKD","LU1282649141.HKD","LU0205194284.USD","LU1048596156.SGD","LU2294711473.HKD","HK0000914660.USD","LU0541501648.USD","SNVDAmain","LU2357305700.SGD","LU0545039389.USD","LU0048584097.USD","LU2420271590.USD","SNPE","LU2264538146.SGD","SG9999000418.SGD","BK4567","SG9999014674.SGD","LU2054465674.USD","IE00B7SZL793.SGD","LU1988902786.USD","LU0048580855.USD","LU2360032135.SGD","MCHmain","LU0594300419.USD","LU0957808578.USD","LU1116320737.USD","LU0265550946.USD","LU0354030438.USD","SPTE","LU0205193047.USD","BK1521","LU1035775433.USD","SG9999018857.SGD","FTEC","LU0456846285.SGD","LU1496350171.SGD","LU0787776722.HKD","LU1642822529.SGD","LU1066053197.SGD","LU1935043023.USD","LU2236285917.USD","LU0965509010.AUD","LU2272731865.HKD","ABFL","LU0472753341.HKD","BK4527","01801","IE0001KFT4U8.USD","LU2083900584.USD","BK4581","HK0000320264.USD","IE00BQXX3C00.GBP","LU0029874905.USD","LU1481107354.HKD","LU1960683339.HKD","LU2125909916.SGD","LU2213496289.HKD","IE00BMPRXR70.SGD","LU1048484197.HKD","LU0096374516.USD","LU0210527791.USD","LU1979441026.SGD","ILDR","BK4020","LU0210533765.USD","LU0871576103.HKD","LU1993786604.SGD","LU0359201885.HKD","LU0918141887.USD","LU0708995153.HKD","COHR","LU0469268626.HKD","LU2257852520.SGD","LU0823426308.USD","LU0762541174.USD","LU0831093199.SGD","IE00BMPRXN33.USD","IE00B543WZ88.USD","LU0516422440.USD","LU1868838027.USD","NVIW.SI","LU0061477393.USD","LU1861220033.SGD","LU0889565833.HKD","LU2097829019.USD","IE00BJJMRY28.SGD","LU0061474705.USD","BK1517","LU1935042488.USD","LU2860962120.EUR","LU1244550577.SGD","LU0261947096.USD","IXN","IE00BJLML261.HKD","LU0661504455.SGD","LU1769817096.USD","LU2272731600.USD","LU2097828805.USD","ANV","LU2471134952.CNY","LU0132412106.USD","LU0048597586.USD","SGXZ23171101.USD","LU0965509283.SGD","LU0608807946.USD","LU0261950983.USD","LU0700851271.USD","LU2491050071.SGD","MHImain","LU1914381329.SGD","LU2756315318.SGD","LU0084288322.USD","LU2125154778.USD","TRFK","LU0762542818.HKD","LU2097344357.USD","LITE","LU2954938101.SGD","LU2089283258.USD","LU0308772762.SGD","LU0210528500.USD","LU2089284900.SGD","SG9999014898.SGD","LU2471134796.USD","513600","HBBD.SI","LU0307460666.USD","LU0588545904.SGD","LU1282649810.SGD","LU0320765059.SGD","LU2247934214.USD","LU0593848301.USD","LU1633808545.USD","BK4588","BK4550","LU0234570918.USD","LU0165289439.USD","NVDQ","CHAT","LU2505996509.AUD","LU0234572021.USD","LU0047713382.USD","LU1044874839.SGD","LU2461242641.AUD","SG9999015945.SGD","LU1992135399.USD","IE00BZ08YS42.EUR","LU1366192091.USD","LU2463028550.USD","LU0557290698.USD","LU0463099449.HKD","LU1439103000.SGD","LU0672654166.SGD","LU1003077747.HKD","LU1718418525.SGD","LU0244354667.USD","LU0868494617.USD","BK4605","LU0328353924.USD","HK0000320223.HKD","LU2087625088.SGD","LU0117841782.USD","IE00BJTD4N35.SGD","LU2077746001.SGD","SG9999015986.USD","LU1145028129.USD","LU0348816934.USD","LU0737861699.HKD","LU0823040885.USD","LU2108987350.USD","LU0965508806.USD","LU1670756490.USD","SG9999001903.USD","LU0957791311.USD","LU0130518102.USD","SGXZ80539844.SGD","BK4587","LU2023250330.USD","LU2279689827.SGD","LU0265550359.USD","LU2125154935.USD","NVII","LU2294711713.HKD","LU2063271972.USD","LU2237443465.HKD","IE00B1XK9C88.USD","LU0133085943.USD","LU2931357623.SGD","IE0004086264.USD","LU0106252389.USD","LU0143863784.USD","IE000KEQY171.SGD","LU0210536198.USD","LU0640798160.USD","LU1366334578.USD","LU1642822792.SGD","LU0862451753.SGD","LU0594300179.USD","LU2237957902.USD","LU1035773651.USD","BK4534","HK0000151867.HKD","THMR","LU0943347566.SGD","COHX","LU0370786039.SGD","LU0823038988.USD","LU1815336760.USD","BK1501","IE00BD6J9T35.USD","LU0314109678.HKD","SOXQ","BK4579","LU0057025933.USD","SG9999014914.USD","LU0886674414.USD","LU0890818403.SGD","LU1044876610.USD","LU1201861165.SGD","BK1618","LU0431992006.USD","LU1115378108.SGD","LU0494093205.USD","LU0359202008.SGD","02833","LU1778281490.HKD","LU2506951792.HKD","IE00B5949003.HKD","LU2505996681.GBP","LU2047632596.USD","LU0965509101.SGD","LU1674673691.USD","LU1769817179.HKD","LU0149721374.USD","LU0157215616.USD","LU1721428933.USD","LU2458330243.SGD","HK0000165453.HKD","IE0031619046.USD","IE00BKPKM429.USD","LU1127390331.HKD","LU0289961442.SGD","LU1934455277.USD","LU2399975544.HKD","LU2413666426.HKD","LU1551013425.SGD","LU0107464264.USD","SG9999000459.SGD","WISE","LU0531971595.HKD","LU0203202063.USD","LU2456880835.USD","LU0831103253.SGD","IE00B0JY6N72.USD","LU0516422952.EUR","LU0708995401.HKD","SG9999014567.USD","LU2552382132.HKD","LU0828237940.HKD","HSTECH","LU0708995583.HKD","LU0266013472.USD","LU0342679015.USD","LU0640476718.USD","LU0540923850.HKD","LU0061475181.USD","LU1188198961.HKD","LU1880383366.USD","IE00BZ199S13.USD","IE00B19Z4B17.USD","LU1861127337.USD","LU1814569148.SGD","07200","LU1571399168.USD","LU2097828631.EUR","LU2417539215.USD","LU0029864427.USD","LU1770036033.HKD","SG9999014575.USD","LU1956131251.USD","LU0577902611.USD","LU1251922891.USD","LU0345769128.USD","CMAG","HK0000306701.USD","LU0289960550.SGD","LU1934455194.USD","LU2326559502.SGD","LU0499858438.USD","COHC","02800","IE00B775SV38.USD","LU0054237671.USD","LU1732800096.USD","LU0096364046.USD","LU2237438978.USD","07388","LU0588545730.USD","LU2756315664.SGD","BK4608","LU0079474960.USD","LU0106261372.USD","LU1153585028.USD","AGOX","LU1720051017.SGD","LU1935042991.SGD","NVDX","LU0320764243.SGD","LU0588546209.SGD","TYLG","LFGY","IE00B3SWFQ91.USD","LU1688375341.USD","LU0197773160.USD","IE000Q6AESB8.SGD","LU0345768153.USD","LU1066051811.HKD","LU2111349929.HKD","HK0000914686.HKD","IE00BWXC8680.SGD","DIPS","LU0823421333.USD","SG9999015952.SGD","SG9999001424.SGD","NVDA","IE000W1ABFV2.USD","LU1400636657.SGD","SGXZ86797644.SGD","IE0032431581.USD","LU0316494557.USD","LU0158827781.USD","LU1267930573.SGD","IE00BK4W5M84.HKD","LU0130103400.USD","LU1400636574.HKD","LU1821325948.USD","IE00BDCRKT87.USD","SG9999017495.SGD","IE0005OL40V9.USD","LU0348827113.USD","LU0788109477.HKD","LU0174119429.USD","LU1066051225.USD","SG9999014542.SGD","LU1989764748.USD","IE00B3S45H60.SGD","IE0004445239.USD","BK1608","LU1868837300.USD","LU0648948544.HKD","03115","LU0345776255.USD","IE0034235295.USD","LU1023057109.AUD","LU1202635105.USD","LU0449509016.USD","LU0238689110.USD","LU0251132253.USD","LU1974910355.USD","LU0541502299.USD","LU0630378429.USD","LU0543330566.HKD","LU0882574139.USD","LU0082616367.USD","LU2250418816.HKD","LU0077335932.USD","LU1366333091.USD","LU0323240290.USD","LU0390134368.USD","SGXZ31699556.SGD","IE0009G5SDU7.USD","LU0231483743.USD","LU1951200564.SGD","LITC","LU1328277881.USD","LU0229945570.USD","LU0444971666.USD","LU2361044865.SGD","IE0003U64NQ7.SGD","LU0353189763.USD","3NVD.UK","LU0795875086.SGD","LU0784639295.USD","LU0348783662.USD","LU0795875169.SGD","LU0985320562.USD","LU1267930490.SGD","LU0441854154.USD","LU2089985449.USD","LU1282651048.USD","LU2097828474.EUR","SG9999006597.SGD","LU2244417387.USD","IE0004091025.USD","LU2237443622.USD","LU2168564495.EUR","LU0561508036.HKD","LU0942090050.USD","NVDS","LU2039709279.SGD","LU0516423091.SGD","BK1615","LU1813983027.USD","LU0170899867.USD","LU0912757837.SGD","LU0502904849.HKD","LU2097828714.EUR","LU2361044949.HKD","LU1923622614.USD","LU0820562030.AUD","SGXZ62798434.SGD","LU0348788117.USD","83115","LU0898667661.SGD","BK4614","BK4529","LU2168564222.USD","LU1280957306.USD","LU1551013342.USD","BK4533","LU2462591350.SGD","IE00B66KJ199.SGD","IE0009356076.USD","IE00B19Z8W00.USD","LU2357125470.USD","NVD","IE00BJJMRX11.SGD","LU0528227936.USD","LU1282648689.USD","TEK","LU0823434583.USD","VT","07788","LU0274383776.USD","LU0823414551.USD","LU1868836914.USD","LU2471134879.HKD","LU2237443978.SGD","BK4548","IE00B19Z8X17.USD","LU2476274720.SGD","IE0034235188.USD","NVYY","LU0820561818.USD","LU1852331112.SGD","IE00BZ08YR35.GBP","LU0820561909.HKD","LU1044875133.USD","LU1923622291.USD","LU2242644610.SGD","LU2125909247.SGD","LU0353189680.USD","LU2106854487.HKD","LU0287142896.SGD","LU0553294199.USD","LU1316542783.SGD","SMHX","LU2168563687.JPY","LU2449936058.SGD","LU1791710400.SGD","LU2403377893.USD","LU0323239441.USD","LU0719512351.SGD","SPRX","LU0396098781.USD","LU2746668461.USD","NULC","LU0164865239.USD","LU0543330483.HKD","LU0823413587.USD","LU0856984785.SGD","LU2361045086.USD","BK4141","LU0097036916.USD","IE00B4JS1V06.HKD","LU0762540952.USD","LU0140636845.USD","LU0918141705.HKD","SG9999001226.SGD","LU0240877869.USD","SG9999015341.SGD","LU0873338254.USD","LU0072462426.USD","LU2087589342.USD","HK0000304797.USD","KWEB","LU0109392836.USD","LU1951198990.SGD","LU1548497426.USD","LU1069344957.HKD","LU1810669033.SGD","LU2065169927.USD","LU2271345857.HKD","LU0791590937.USD","LU2087621335.USD","LU0577902454.USD","SG9999014559.SGD","FDTX","LU1804176565.USD","LU2462157665.USD","LU0823413660.USD","IE00BQXX3D17.EUR","METV","IE00BFSS7M15.SGD","ARTY","LU0240878834.USD","LU1923623000.USD","LU1323610961.USD","LU3063872942.SGD","LU0359201612.USD","SG9999004303.SGD","LU0724617625.USD","LU1069347547.HKD","LU2430703178.SGD","IE00BK4W5L77.USD","LU1989764664.SGD","LU0642271901.SGD","LU1196710864.SGD","FOTO","LU0043850808.USD","LU0053666078.USD","LU0348723411.USD","LU0511384066.AUD","LU1144417596.USD","LU2065171402.SGD","LU0348814723.USD","LU1105468828.SGD","LU0264606111.USD","LU2360106780.USD","IE00BDRTCR15.USD","LU0797268264.HKD","82800","09115","LU0154236417.USD","LUMA","IE00B19Z9505.USD","LU0256863902.USD","BK1161","NVD2.UK","BK4503","LU1261432733.SGD","LU0348825331.USD","SGXZ99366536.SGD","LU0128525929.USD","LU0289739343.SGD","IE00BPRC5H50.USD","LU0048388663.USD","LU2750360997.AUD","LU0786609619.USD","LU2328871848.SGD","LU0158827948.USD","LU0417516902.SGD","SG9999001689.USD","LU0417516738.SGD","LU0648000940.SGD","LU2023250504.SGD","LU0607220059.USD","LU0455707207.USD","LU0456827905.SGD","LU0651946864.USD","BK1591","LU2191332357.HKD","07300","LU0128522744.USD","LU2168564065.EUR","LU1568876251.USD","LU0823397103.USD","LU2133065610.SGD","LU2265009873.SGD","BK4543","LU0572940350.SGD","LU0577902298.EUR","LU1048588211.SGD","LU0821914370.USD","LU1839511570.USD","LU0052750758.USD","ESUM","LU1880398554.USD","LU0049853897.USD","LU1400636491.USD","LU0348784397.USD","LU1211504680.USD","LU2452424414.USD","LU0164872284.USD","LU2458330169.SGD","LU0327786744.USD","LU1242518931.SGD","LU1868836591.USD","LU2211815571.USD","LU2237443549.SGD","LU0828237510.HKD","LU0823426480.USD","LITG","LU1880398471.USD","LU2488822045.USD","BABA","LU1242518857.USD","LU1366334651.USD","LU0128522157.USD","LU0862451837.USD","LU1868836757.USD","CXSE","LU0516423174.USD","LU0181495838.USD","LU1989772923.USD","SG9999014906.USD","LU1934455863.HKD","LU0823041008.USD","LU1224444064.USD","LU2065170008.USD","LU2237443895.HKD","LU1303224171.USD","BK4532","LU1880383440.USD","LU0395794307.EUR","LU2045819591.USD","IE00BYXW3230.USD","LU0477156797.USD","LU0588545490.SGD","LU1051768304.USD","LU0979878070.USD","LU0577902371.SGD","LU2413666699.HKD","LU2471134523.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662276478","title":"Hong Kong's SSY Group H1 Profit Rises on Infusion Solutions Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2662276478","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662276478?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:16","pubTimestamp":1787717785,"startTime":"0","endTime":"0","summary":"Hong Kong's SSY Group H1 profit rises on infusion solutions growthOverviewHong Kong pharmaceutical maker's H1 revenue rose 9.9% yr/yr to HK$2,361 mlnNet profit attributable to shareholders rose 13% to","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N037:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","LU2460026573.USD","BK1583","02005","LU0244354667.USD","LU2097828631.EUR","LU0455707207.USD","LU1969619763.USD","BK1161","KURE","01801","LU0326950275.SGD","LU2242644610.SGD","LU0502904849.HKD","LU2097828557.USD","LU2097828474.EUR","LU2328871848.SGD","BK1589","LU0463099449.HKD","BK1191","LU2488822045.USD","LU2097828714.EUR","LU1188198961.HKD","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662176420","title":"Sihuan Pharmaceutical H1 Profit Jumps on Medical Aesthetics Unit Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2662176420","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662176420?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:15","pubTimestamp":1787717732,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical H1 profit jumps on medical aesthetics unit strengthOverviewChina pharmaceutical group's interim revenue rose 1.3% yr/yr, led by medical aesthetics growthNet income attributable t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N039:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","LU0244354667.USD","LU1152091168.USD","LU1226288253.USD","LU1008478684.HKD","SG9999004220.SGD","LU2097828631.EUR","LU1152091754.HKD","LU1960683339.HKD","IE00BZ08YS42.EUR","IE00B543WZ88.USD","BK1589","LU2242644610.SGD","LU0314109678.HKD","LU0463099449.HKD","LU1188198961.HKD","BK1191","BK1600","LU2097828805.USD","LU0502904849.HKD","BK1583","IE0008369823.USD","HK0000165453.HKD","688428","LU1813983027.USD","LU2097828714.EUR","LU0072913022.USD","LU0455707207.USD","IE00B031HY20.USD","LU2039709279.SGD","BK1161","00460","BK1515","LU1328277881.USD","LU0140636845.USD","01801","BK1593","LU0067412154.USD","LU1226287529.USD","LU1226288170.HKD","LU2097828474.EUR","LU1807302812.USD","LU2328871848.SGD","01093","LU0880133367.SGD","LU1969619763.USD","KURE","LU2488822045.USD","BK0239","LU0501845795.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154655464","title":"Morning Market Wrap: Hong Kong Shares Rise 0.68% as Copper Stocks Take the Lead","url":"https://stock-news.laohu8.com/highlight/detail?id=1154655464","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154655464?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:07","pubTimestamp":1787717221,"startTime":"0","endTime":"0","summary":"Hong Kong's benchmark index kicked off the morning session with a 0.68% gain, advancing 174 points to reach 25,685 points, while the tech-heavy Hang Seng Tech Index climbed a more robust 1.58%....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02800","07200","BK1233","600999","LU0417516571.SGD","IE00B543WZ88.USD","IE00BVYPNP33.GBP","IE0031814852.USD","LU0348784397.USD","LU0594300179.USD","LU0607220059.USD","LU0359202008.SGD","IE0008368742.USD","IE00B031HY20.USD","07552","07500","BK1147","LU0320764599.SGD","LU2039709279.SGD","513600","03032","LU1328277881.USD","BK1594","HSImain","01828","LU0181495838.USD","HHImain","688185","LU0052750758.USD","BK1237","IE00BYV24P56.USD","03423","KURE","LU0149721374.USD","02833","00358","IE00B5MMRT66.SGD","LU0828237940.HKD","SG9999002828.SGD","09926","LU0244354667.USD","83115","600362","601995","LU0348827113.USD","06831","06969","BK1501","LU2213484517.USD","SG9999002950.SGD","603083","BK1227","03417","SG9999004311.SGD","BK1521","LU0405327148.USD","SG9999004220.SGD","HSI","LU0862451837.USD","BK1597","LU1961090484.USD","LU2187417386.USD","LU0348735423.USD","HSTECH","LU2351347302.SGD","LU1048596156.SGD","BK1580","01112","LU0348766576.USD","02837","LU0821914370.USD","LU1481107354.HKD","IE00BGHQDM52.EUR","06166","LU2476274308.USD","BK1161","LU0149534421.HKD","IE00BZ08YS42.EUR","LU1880383440.USD","HTImain","LU0314109678.HKD","BK1568","603993","LU1188198961.HKD","03033","BK1191","LU1023057109.AUD","BK1589","IE00BMCWC346.EUR","IE00B031J352.USD","06185","07300","LU1831875114.USD","LU1880383366.USD","LU0348767384.USD","LU0417516738.SGD","LU0417516902.SGD","LU0594300419.USD","IE0008369823.USD","LU0463099449.HKD","IE00B29SXG58.USD","BK1574","03037","LU0359201612.USD","LU0708995583.HKD","LU1813983027.USD","09088","LU0348825331.USD","BK1149","BK1592","LU1794554557.SGD","IE00BZ08YR35.GBP","02313","LU0326950275.SGD","09067","82800","LU0890818403.SGD","LU1102505762.USD","LU2125910500.SGD","LU2476274720.SGD","03067","IE00BPRC5H50.USD","06099","IE00BZ08YT58.USD","BK1206","LU0140636845.USD","BK1184","LU0405327494.USD","LU0164880469.USD","LU1720050803.USD","03993","MCHmain","LU2399975544.HKD","IE00BVYPNQ40.USD","09115","07226","LU0650527681.SGD","LU2045819591.USD","LU2778985437.USD","LU1102505929.USD","02575","LU0605514214.HKD","BK1515","BK1564","BK1516","BK1513","03088","SG9999014674.SGD","LU2488822045.USD","01258","BK1240","LU0359201885.HKD","LU0540923850.HKD","03419","BK1242","LU0862451753.SGD","03115","LU0348783233.USD","LU0634319403.HKD","LU2929501877.USD","LU0561508036.HKD","BK1553","03908","BK1190","HK0000286598.CNH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128522297","title":"Mainland Benchmarks Edge Higher in Morning Trade; Nonferrous Metals and Brokerages Lead While Optical Modules Retreat; Hang Seng and Tech Index Climb Over 1% on Biotech Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1128522297","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128522297?lang=en_us&edition=fundamental","pubTime":"2026-08-26 10:38","pubTimestamp":1787711889,"startTime":"0","endTime":"0","summary":"Mainland Chinese equities extended gains on August 26, with all three major indices moving higher in early trading. Precious and base metals sustained their upward momentum, while brokerages and...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03088","07552","82800","HHImain","LU2328871848.SGD","03115","LU1655091616.SGD","BK0028","HSI","HSImain","LU0067412154.USD","01801","161726","07200","LU1969619763.USD","LU2097828557.USD","LU0244354667.USD","09088","LU0501845795.SGD","LU0880133367.SGD","IE00B0JY6N72.USD","KURE","LU2242644610.SGD","BK0201","LU0463099449.HKD","09067","07300","LU1188198961.HKD","03067","LU2097828631.EUR","BK0187","03419","513600","LU2097828714.EUR","HTImain","03032","MCHmain","LU2488822045.USD","BK1589","09115","83115","LU1807302812.USD","07226","03423","LU1781817850.SGD","03417","BK0188","07500","LU1226287529.USD","02837","BK0278","02833","03037","BK1161","LU1580142542.USD","LU0455707207.USD","BK0183","LU0072913022.USD","03033","BK0012","LU1993786604.SGD","HSTECH","HK0000165453.HKD","000001","LU0502904849.HKD","02800","BK1583","LU0326950275.SGD","LU2097828805.USD","LU2097828474.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662769060","title":"China's Akeso Jumps on Progress of Immunotherapy Drug for Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662769060","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662769060?lang=en_us&edition=fundamental","pubTime":"2026-08-26 10:33","pubTimestamp":1787711596,"startTime":"0","endTime":"0","summary":"BUZZ-China's Akeso jumps on progress of immunotherapy drug for cancer treatment** Shares of China-based drug developer Akeso Inc9926.HKjump 9% to HK$96.9, on track for the biggest one-day pct gain since June 29** Stock hits the highest level since August 20 in the second gaining session** Akeso saysivonescimab plus chemomeets primary endpoint with significant overall survival benefit versus durvalumab plus chemo in phase III clinical study for the first-line treatment of advanced biliary tract cancer** The study met all key secondary endpoints of progression-free survival and objective response rate - Co** YTD, stock down 14.8%, while Hang Seng Biotech Index.HSBIOup 15.7%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N025:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B543WZ88.USD","LU2476274308.USD","LU0540923850.HKD","LU0417516738.SGD","LU2399975544.HKD","09926","LU0348735423.USD","KURE","LU1720050803.USD","LU0348784397.USD","LU2778985437.USD","BK1161","IE00B5MMRT66.SGD","BK1574","LU0561508036.HKD","LU0348766576.USD","LU0417516902.SGD","IE00BPRC5H50.USD","LU1794554557.SGD","LU2488822045.USD","LU0348825331.USD","LU0417516571.SGD","LU1961090484.USD","LU0348827113.USD","LU2476274720.SGD","LU0348783233.USD","LU0348767384.USD","LU0634319403.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147226125","title":"AKESO Surges Over 9% in Session as Evonex Achieves Positive Phase III Results in Biliary Tract Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1147226125","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147226125?lang=en_us&edition=fundamental","pubTime":"2026-08-26 10:31","pubTimestamp":1787711462,"startTime":"0","endTime":"0","summary":"Shares of AKESO (09926) surged more than 9% during intraday trading before paring gains to trade 6.81% higher at HK$94.85, with turnover reaching HK$814 million. The sharp move followed the company's...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1794554557.SGD","LU0348735423.USD","09926","LU1961090484.USD","IE00BPRC5H50.USD","LU0417516902.SGD","LU0348783233.USD","LU0561508036.HKD","LU2488822045.USD","LU0348827113.USD","LU0417516738.SGD","LU1720050803.USD","III","LU2778985437.USD","LU0540923850.HKD","LU0417516571.SGD","KURE","IE00B543WZ88.USD","LU0348766576.USD","LU0348784397.USD","LU2476274308.USD","LU0634319403.HKD","IE00B5MMRT66.SGD","LU0348767384.USD","BK1574","LU2476274720.SGD","BK1161","LU2399975544.HKD","BK4134","LU0348825331.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662766269","title":"Akeso's Ivonescimab Meets Primary Endpoint in Phase 3 Biliary Tract Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662766269","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662766269?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:41","pubTimestamp":1787708502,"startTime":"0","endTime":"0","summary":"Akeso  said its PD-1/VEGF bispecific antibody ivonescimab plus chemotherapy met the primary endpoint in a Phase 3 trial for first-line treatment of advanced biliary tract cancer.The trial met its primary endpoint of overall survival, with key secondary endpoints of progression-free survival and objective response rate also met, according to a Wednesday filing with the Hong Kong bourse.The HARMONi-GI1 study enrolled 682 patients, marking ivonescimab's first positive Phase 3 result in gastrointestinal tumors, Akeso said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","KURE","IE00B5MMRT66.SGD","LU2399975544.HKD","LU2476274720.SGD","LU1720050803.USD","09926","IE00B543WZ88.USD","LU0348825331.USD","LU0348784397.USD","LU0561508036.HKD","LU2778985437.USD","LU1961090484.USD","LU0348783233.USD","LU2476274308.USD","IE00BPRC5H50.USD","BK1161","LU0348827113.USD","LU0348766576.USD","LU0417516902.SGD","LU0417516738.SGD","LU0634319403.HKD","LU0540923850.HKD","LU2488822045.USD","LU1794554557.SGD","LU0348767384.USD","LU0417516571.SGD","LU0348735423.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}